SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-017184
Filing Date
2023-05-03
Accepted
2023-05-03 16:11:45
Documents
14
Period of Report
2023-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgnx-20230503.htm   iXBRL 8-K 55781
2 EX-99.1 rgnx-ex99_1.htm EX-99 337860
3 GRAPHIC img101737798_0.jpg GRAPHIC 14369
  Complete submission text file 0000950170-23-017184.txt   551819

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgnx-20230503_lab.xml EX-101.LAB 13474
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgnx-20230503.xsd EX-101.SCH 2460
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgnx-20230503_pre.xml EX-101.PRE 9894
8 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-20230503_htm.xml XML 4739
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 23883842
SIC: 2836 Biological Products, (No Diagnostic Substances)